Arkolith/Insider Trading/TRML/Form 4

Castelein Caley

DirectorTourmaline Bio, Inc. (TRML) · full profile →Form 4 · filed Oct 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 19, 2023Grant(A)497K——497K
Oct 19, 2023Grant(A)458K——458K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 23, 2023Grant(A)10K—$010K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-053389) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML